Helpful Links
Residency Program
About the Program
Location: Huntsville, TX
The PGY1 Pharmacy Practice Residency was established in 1993 and has been accredited by ASHP since 1994. It is a 52-week program that builds on Doctor of Pharmacy (PharmD) education and outcomes to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives. Residents who successfully complete PGY1 residency programs will be skilled in diverse patient care, practice management, leadership, and education, and be prepared to provide patient care, seek board certification in pharmacotherapy (i.e., BCPS), and pursue advanced education and training opportunities including postgraduate year two (PGY2) residencies.
The intent is to provide residents with a well-rounded clinical, administrative, and practice management experience. The residency structure is largely longitudinal. The goal is to provide the resident experience in time and resource management and to provide a realistic practice model for practitioners.
During the PGY1 pharmacy residency program, the resident is actively involved in the provision of pharmaceutical care by providing patient care, drug information, participating in system and management operations, and working on assigned projects. The majority of experience is gained in ambulatory care.
Required Rotations
- Orientation
- Longitudinal Practice Foundation Skills
- Practice Management I
- Longitudinal Staffing Rotation
- Longitudinal Ambulatory Care
- Longitudinal Psychiatry or Longitudinal Anticoagulation Management
- Drug Information & Policy Development
Elective Rotations
- Anticoagulation
- Chronic Kidney Disease
- Diabetes
- Hepatitis C
- Non-formulary
- Psychiatry
- Hypertension
- Medication Reconciliation
- Practice Management II
Research Project
The resident is required to complete a research project suitable for presentation at the Alcalde Southwest Leadership Conference for Residents, Fellows, and Preceptors and as a poster presentation at the ASHP Midyear Clinical Meeting.
Completion of Program Requirements & Residency Certificate
Upon successful completion of all program requirements and compliance with all conditions of the residency program, the resident will be awarded a certificate of completion.
All of the following criteria must be satisfied to successfully complete the program:
- The resident must obtain a minimum score of “satisfactory progress” on all required program goals and objectives at the time of final evaluation. The resident must also attain an Achieved for Residency (ACHR) score for 75% of all goals and objectives of the residency program and 75% of Competency Area R1 Objectives.
- The resident must have completed all self-evaluations and preceptor/rotation evaluations.
- The resident must have completed the major project and manuscript of publishable quality. The major project must be reviewed and approved by the Residency Program Director.
- The resident must satisfactorily complete the following:
- a minimum of 3 formal special projects (e.g medication use evaluation which goes to the P&T committee, nursing CLP for sterile compounding, editor of the Pharmacy Pill Pass Newsletter) approved by the Residency Program Director (maximum of 10)
- a minimum of 1 Journal Club presentations (maximum of 10)
- a minimum of 7 case/topic presentations (maximum of 12)
- a minimum of 4 formally written drug information questions (maximum of 10)
In order to receive a residency certificate, these requirements must be met by the end of the final evaluation period. The residency certificate of completion will not be issued without satisfactory completion of the residency project and required assignments, and demonstration that goals have been met as measured in rotation and quarterly evaluations. In addition, the program will not be extended and the resident will not be awarded the residency certificate if the resident fails to complete the residency program requirements during the 12 months allotted to the program. The resident may be dismissed if evaluation scores for two consecutive evaluations indicate improvement is needed (NI) in the same performance area.
Nondiscrimination, Equal Employment Opportunity, and Affirmative Action
UTMB is committed to equal employment opportunities for all employees and applicants for employment. It accepts the obligation as a member of the community at large and as a government employer to exercise an active and positive program of non-discrimination in all areas of employment. Employment decisions are made by providing equal opportunity and access on the basis of qualifications and merit. This includes, but is not limited to, recruitment, promotion, compensation, benefits, and training.
Application Process The application deadline is January 8, 2024
Application materials should be submitted through PhORCAS and include:
- Curriculum vitae
- Three references from pharmacy practitioners
- School transcripts
- Letter of intent
Additional requirements for all matched applicants:
- PharmD degree from an ACPE-accredited institution before the residency start date
- Successful security background check
- Successful pre-employment drug screen
- Documented proof of immunizations required for healthcare workers
- Texas licensure by July 31 unless otherwise approved by the Residency Program Director
Applicants are welcome to contact utmbcmcpharmacyresidency@utmb.edu for further information.